What happens during a C&P exam for Recurrent Joint Effusion?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.

← All Condition Guides

CLAIM RECON INTEL

Recurrent Joint Effusion

Q: What are the VA rating percentages for Recurrent Joint Effusion?

Recurrent Joint Effusion (DC 5299) is rated at 0% under 38 CFR § 4.71a, DC 5299. Per § 4.20: rate under the underlying joint condition that produces the effusion. Common analogs: DC 5003 (Degenerative arthritis) + § 4.59 painful-motion 10% floor; DC 5258 (Cartilage, semilunar, dislocated, with frequent locking + pain + effusion) = 20%; DC 5024 (Tenosynovitis) for tenosynovitis-related effusion; DC 5257 (Knee, recurrent subluxation or lateral instability) for instability-driven effusion.

Q: What rates 0% for Recurrent Joint Effusion under 38 CFR § 4.71a, DC 5299?

Under 38 CFR § 4.71a, DC 5299 (DC 5299), a 0% rating for Recurrent Joint Effusion requires: Per § 4.20: rate under the underlying joint condition that produces the effusion. Common analogs: DC 5003 (Degenerative arthritis) + § 4.59 painful-motion 10% floor; DC 5258 (Cartilage, semilunar, dislocated, with frequent locking + pain + effusion) = 20%; DC 5024 (Tenosynovitis) for tenosynovitis-related effusion; DC 5257 (Knee, recurrent subluxation or lateral instability) for instability-driven effusion.

Q: What evidence do I need for a Recurrent Joint Effusion VA claim?

Key evidence for a Recurrent Joint Effusion claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 5299 | 38 CFR § 4.71a, DC 5299 | 

✓ VERIFIED AGAINST 38 C.F.R.§ 4.71a (Musculoskeletal system) · reviewed 2026-05-27 · ClaimRecon Editorial Team

Recurrent Joint Effusion is rated by the U.S. Department of Veterans Affairs under DC 5299 of 38 CFR § 4.71a, DC 5299 across 1 severity tier (0%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

OVERVIEW

Recurrent accumulation of excess synovial fluid within a joint causing swelling, stiffness, and reduced range of motion

RATING CRITERIA (1 LEVELS)

Per § 4.20: rate under the underlying joint condition that produces the effusion. Common analogs: DC 5003 (Degenerative arthritis) + § 4.59 painful-motion 10% floor; DC 5258 (Cartilage, semilunar, dislocated, with frequent locking + pain + effusion) = 20%; DC 5024 (Tenosynovitis) for tenosynovitis-related effusion; DC 5257 (Knee, recurrent subluxation or lateral instability) for instability-driven effusion.

KEY EVIDENCE TO GATHER

-Service treatment records showing injury or complaints

-Imaging (X-ray, MRI, CT)

-Range of motion measurements

-Flare-up documentation per Sharp v. Shulkin

-Buddy statements describing limitations

-Prescription history

-Physical therapy records

-Employment impact documentation

C&P EXAM TIPS (6)

1.Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2.Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3.Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4.Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5.If you use assistive devices (brace, cane), bring them.

6.Describe daily activity impact: work, sleep, household tasks.

Secondary Conditions Explorer

736 secondaries mapped

Calculate Your Rating

VA math + dollar impact

RELATED TOOLS

Rating Calculator Secondaries Map C&P Exam Prep PACT Act Scanner 2026 Rates

SOURCES & EDITORIAL

Rating criteria text quoted verbatim from 38 C.F.R. § 4.71a (Musculoskeletal system). Source verified 2026-05-27 by ClaimRecon Editorial Team during a regulation-text comparison against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

→ View § 4.71a on eCFR → Cornell Law mirror → Editorial Standards → Suggest a correction

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING